Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 3D-radiotherapy plus amifostine vs IMRT for xerostomia reduction in head and neck cancer
2004-004288-31Phase 2Terminated
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amifostine in head and neck cancer (HNC) (2 arms), sponsored by Istituti Fisioterapici Ospitalieri. Primary endpoint: Reduction of xerostomia. Started Feb 2007; status: terminated.
02
Drugs
amifostine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2004-004288-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004288-31.